Welcome to the online edition of the Journal of Psychiatry and Neuroscience, the official journal of the Canadian College of Neuropsychopharmacology.

Canadian College of Neuropsychopharmacology logo

NEW: As of January 2021, the Journal of Psychiatry and Neuroscience (JPN) will move to an online only format, and the print format will be discontinued. JPN content is currently already freely available online. In 2021 the journal moves to a new content licence, making all content Open Access.  Read more about this change.

The Journal of Psychiatry & Neuroscience publishes papers at the intersection of psychiatry and neuroscience that advance our understanding of the neural mechanisms involved in the etiology and treatment of psychiatric disorders. This includes studies on patients with psychiatric disorders, healthy humans, and experimental animals as well as studies in vitro. Original research articles, including clinical trials with a mechanistic component, and review papers will be considered.

The Journal of Psychiatry & Neuroscience has an impact factor of 6.186 (2020) and is the 3rd highest ranking fully open access journal in Psychiatry.

A high-quality scientific journal could not be produced without the anonymous, unpaid and often inadequately appreciated work of its reviewers. The editors and staff of the Journal of Psychiatry & Neuroscience thank everyone who reviewed submissions to the journal in 2020. View the 2020 Reviewer list.

Email Alerts

Readers of the Journal of Psychiatry and Neuroscience can subscribe to e-mail alerts to receive the table of contents by e-mail when a new issue appears. To subscribe to JPN e-mail alerts, enter your email address below.

Top Viewed Articles

1. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

2. Why is depression more prevalent in women?

3. Treatment of ADHD in patients with bipolar disorder

View entire list